Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Lipocine Operating Cash Flow Per Share 2012-2024 | LPCN

Lipocine operating cash flow per share from 2012 to 2024. Operating cash flow per share can be defined as a measure of financial performance calculated as operating cash flow, expressed on a per share basis
  
Lipocine Operating Cash Flow Per Share Historical Data
Date
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.027B $0.001B
Lipocine, Inc. is a specialty pharmaceutical company. It develops pharmaceutical products for use in men's and women's health. The Company's lead product candidate, LPCN 1021, is in Phase 3 and is targeted to treat symptoms of low testosterone for men in need of testosterone replacement therapy. Its additional pipeline candidates include LPCN 1111, a next generation oral testosterone therapy product, and LPCN 1107, indicated for the prevention of preterm birth and is currently in Phase 1. Lipocine Inc. is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $78.485B 30.20
Takeda Pharmaceutical (TAK) Japan $43.083B 8.97
Merck (MKKGY) Germany $20.756B 22.65
Astellas Pharma (ALPMY) Japan $19.764B 18.20
Sandoz Group AG (SDZNY) Switzerland $19.412B 0.00
United Therapeutics (UTHR) United States $17.897B 17.60
Summit Therapeutics (SMMT) United States $15.309B 0.00
Neurocrine Biosciences (NBIX) United States $12.859B 34.05
Shionogi (SGIOY) Japan $12.188B 11.68
Catalent (CTLT) United States $10.755B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.722B 7.55
Madrigal Pharmaceuticals (MDGL) United States $7.395B 0.00
Orion OYJ (ORINY) Finland $6.653B 18.71
Corcept Therapeutics (CORT) United States $6.055B 45.87
Ionis Pharmaceuticals (IONS) United States $5.964B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.704B 0.00
PTC Therapeutics (PTCT) United States $3.441B 0.00
Dyne Therapeutics (DYN) United States $2.945B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.863B 17.13
Catalyst Pharmaceuticals (CPRX) United States $2.748B 12.45
Arrowhead Pharmaceuticals (ARWR) United States $2.674B 0.00
Soleno Therapeutics (SLNO) United States $2.471B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.229B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.131B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.926B 0.00
Harrow (HROW) United States $1.771B 0.00
Xencor (XNCR) United States $1.659B 0.00
Ocular Therapeutix (OCUL) United States $1.653B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.620B 0.00
ARS Pharmaceuticals (SPRY) United States $1.610B 0.00
Evotec AG (EVO) Germany $1.573B 0.00
Indivior (INDV) United States $1.404B 5.72
Guardian Pharmacy Services (GRDN) United States $1.377B 0.00
Enliven Therapeutics (ELVN) United States $1.283B 0.00
Cassava Sciences (SAVA) United States $1.269B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.266B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.200B 0.00
Ardelyx (ARDX) United States $1.087B 0.00
Collegium Pharmaceutical (COLL) United States $1.013B 5.53
Bioventus (BVS) United States $0.959B 30.36
Cronos Group (CRON) Canada $0.864B 0.00
Relay Therapeutics (RLAY) United States $0.795B 0.00
USANA Health Sciences (USNA) United States $0.772B 14.32
Exscientia (EXAI) United Kingdom $0.739B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.702B 0.00
Altimmune (ALT) United States $0.674B 0.00
Tourmaline Bio (TRML) United States $0.671B 0.00
Savara (SVRA) United States $0.630B 0.00
Korro Bio (KRRO) United States $0.606B 0.00
Elite Pharmaceuticals (ELTP) United States $0.598B 56.01
ProKidney (PROK) United States $0.594B 0.00
Larimar Therapeutics (LRMR) United States $0.577B 0.00
Verve Therapeutics (VERV) United States $0.543B 0.00
OmniAb (OABI) United States $0.531B 0.00
Siga Technologies (SIGA) United States $0.504B 5.88
Silence Therapeutics (SLN) United Kingdom $0.485B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.479B 194.43
Esperion Therapeutics (ESPR) United States $0.479B 0.00
Xeris Biopharma Holdings (XERS) United States $0.470B 0.00
KalVista Pharmaceuticals (KALV) United States $0.461B 0.00
Organogenesis (ORGO) United States $0.457B 0.00
Aquestive Therapeutics (AQST) United States $0.455B 0.00
Zevra Therapeutics (ZVRA) United States $0.451B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.436B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.428B 0.00
Akebia Therapeutics (AKBA) United States $0.425B 0.00
4D Molecular Therapeutics (FDMT) United States $0.409B 0.00
Sage Therapeutics (SAGE) United States $0.351B 0.00
Avita Medical (RCEL) United States $0.332B 0.00
Lyell Immunopharma (LYEL) United States $0.325B 0.00
Nature's Sunshine Products (NATR) United States $0.303B 18.05
Aldeyra Therapeutics (ALDX) United States $0.283B 0.00
Pyxis Oncology (PYXS) United States $0.275B 0.00
Acrivon Therapeutics (ACRV) United States $0.260B 0.00
Lexeo Therapeutics (LXEO) United States $0.254B 0.00
Nektar Therapeutics (NKTR) United States $0.242B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.226B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.219B 0.00
Profound Medical (PROF) Canada $0.196B 0.00
Heron Therapeutics (HRTX) United States $0.194B 0.00
Nanobiotix S.A (NBTX) France $0.190B 0.00
Galectin Therapeutics (GALT) United States $0.184B 0.00
Incannex Healthcare (IXHL) Australia $0.184B 0.00
Aclaris Therapeutics (ACRS) United States $0.183B 0.00
MediWound (MDWD) Israel $0.182B 0.00
Achieve Life Sciences (ACHV) Canada $0.160B 0.00
Context Therapeutics (CNTX) United States $0.154B 0.00
Cardiol Therapeutics (CRDL) Canada $0.153B 0.00
CytoDyn (CYDY) United States $0.152B 0.00
VAXART, INC (VXRT) United States $0.128B 0.00
Telomir Pharmaceuticals (TELO) United States $0.124B 0.00
Century Therapeutics (IPSC) United States $0.120B 0.00
Fractyl Health (GUTS) United States $0.116B 0.00
Journey Medical (DERM) United States $0.113B 0.00
Karyopharm Therapeutics (KPTI) United States $0.113B 0.00
Innate Pharma SA (IPHYF) France $0.103B 0.00
Regulus Therapeutics (RGLS) United States $0.102B 0.00
Relmada Therapeutics (RLMD) United States $0.100B 0.00
Arch Biopartners (ACHFF) Canada $0.094B 0.00
OptiNose (OPTN) United States $0.090B 0.00
Citius Pharmaceuticals (CTXR) United States $0.087B 0.00
CASI Pharmaceuticals (CASI) China $0.087B 0.00
PMV Pharmaceuticals (PMVP) United States $0.086B 0.00
Metagenomi (MGX) United States $0.083B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Assertio Holdings (ASRT) United States $0.081B 21.30
ElectroCore (ECOR) United States $0.080B 0.00
Inotiv (NOTV) United States $0.079B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 369.00
Vivani Medical (VANI) United States $0.069B 0.00
Prelude Therapeutics (PRLD) United States $0.063B 0.00
Champions Oncology (CSBR) United States $0.063B 0.00
AlloVir (ALVR) United States $0.062B 0.00
Mural Oncology (MURA) Ireland $0.060B 0.00
Nutriband (NTRB) United States $0.056B 0.00
Protara Therapeutics (TARA) United States $0.053B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
SCYNEXIS (SCYX) United States $0.051B 0.00
Rafael Holdings (RFL) United States $0.046B 0.00
Unicycive Therapeutics (UNCY) United States $0.046B 0.00
VYNE Therapeutics (VYNE) United States $0.044B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.044B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.042B 0.00
Carisma Therapeutics (CARM) United States $0.042B 0.00
CERo Therapeutics Holdings (CERO) United States $0.040B 0.00
DURECT (DRRX) United States $0.040B 0.00
FibroGen (FGEN) United States $0.039B 0.00
BioLineRx (BLRX) Israel $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.034B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.033B 0.00
Surrozen (SRZN) United States $0.032B 0.00
Oruka Therapeutics (ORKA) United States $0.032B 0.00
BioVie (BIVI) United States $0.031B 0.00
Tempest Therapeutics (TPST) United States $0.027B 0.00
Natural Alternatives (NAII) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
GlycoMimetics (GLYC) United States $0.026B 0.00
Inhibikase Therapeutics (IKT) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.021B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.020B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.019B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
Talphera (TLPH) United States $0.015B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.015B 0.00
Scienture Holdings (SCNX) United States $0.015B 0.00
Nuvilex (PMCB) United States $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
NRx Pharmaceuticals (NRXP) United States $0.014B 0.00
Avalo Therapeutics (AVTX) United States $0.013B 0.00
Indaptus Therapeutics (INDP) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Dominari Holdings (DOMH) United States $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Conduit Pharmaceuticals (CDT) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Redhill Biopharma (RDHL) Israel $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Viracta Therapeutics (VIRX) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Biomerica (BMRA) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Oncternal Therapeutics (ONCT) United States $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.08
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Phio Pharmaceuticals (PHIO) United States $0.002B 0.00
Molecular Templates (MTEM) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 1.87
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 40.69